Literature DB >> 16794503

Reduced gene expression of clustered ribosomal proteins in Diamond-Blackfan anemia patients without RPS19 gene mutations.

Yuhki Koga1, Shouichi Ohga, Akihiko Nomura, Hidetoshi Takada, Toshiro Hara.   

Abstract

Diamond-Blackfan anemia (DBA) is a rare congenital pure red cell aplasia occasionally presenting physical anomalies. Ribosomal protein S19 gene (RPS19) is one of the causative genes for DBA; however, the pathologic mechanism of erythroblastopenia and abnormal morphology has not been clarified. To assess the pathophysiology of DBA, the gene expression profile of 2 representative patients carrying no RPS19 mutations was compared with that of aplastic anemia (AA) patients, assessed by the microarray analyses. The K-mean clustering analysis revealed the significant categorization of 28 ribosomal protein (RP) genes into a small set of group (994 genes) (P=2.39E-17), all of which were expressed at lower levels in DBA than in AA patients. RPS19 was categorized into the set of low expressing genes in DBA patients. No mutations were determined in the promoter and coding sequences of top 10 RP genes expressed at the levels over 1.2 of the AA/DBA ratio, in 3 DBA patients. These results indicated that the lower expression of RP gene group, even without the mutation, was a distinctive feature of DBA from AA, although the study number was small. The reduced RP gene expression, by itself, may suggest an underlying mechanism of the constitutional anemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16794503     DOI: 10.1097/00043426-200606000-00007

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  5 in total

1.  L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway.

Authors:  Elspeth M Payne; Maria Virgilio; Anupama Narla; Hong Sun; Michelle Levine; Barry H Paw; Nancy Berliner; A Thomas Look; Benjamin L Ebert; Arati Khanna-Gupta
Journal:  Blood       Date:  2012-06-25       Impact factor: 22.113

2.  Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits.

Authors:  Johan Flygare; Anna Aspesi; Joshua C Bailey; Koichi Miyake; Jacqueline M Caffrey; Stefan Karlsson; Steven R Ellis
Journal:  Blood       Date:  2006-09-21       Impact factor: 22.113

3.  Fibroblasts from patients with Diamond-Blackfan anaemia show abnormal expression of genes involved in protein synthesis, amino acid metabolism and cancer.

Authors:  Federica Avondo; Paola Roncaglia; Nicoletta Crescenzio; Helena Krmac; Emanuela Garelli; Marta Armiraglio; Carlotta Castagnoli; Maria Francesca Campagnoli; Ugo Ramenghi; Stefano Gustincich; Claudio Santoro; Irma Dianzani
Journal:  BMC Genomics       Date:  2009-09-18       Impact factor: 3.969

4.  Proerythroblast Cells of Diamond-Blackfan Anemia Patients With RPS19 and CECR1 Mutations Have Similar Transcriptomic Signature.

Authors:  Beren Karaosmanoglu; M Alper Kursunel; Duygu Uckan Cetinkaya; Fatma Gumruk; Gunes Esendagli; Sule Unal; Ekim Z Taskiran
Journal:  Front Physiol       Date:  2021-06-11       Impact factor: 4.566

5.  Identification of novel drug targets for diamond-blackfan anemia based on RPS19 gene mutation using protein-protein interaction network.

Authors:  Abbas Khan; Arif Ali; Muhammad Junaid; Chang Liu; Aman Chandra Kaushik; William C S Cho; Dong-Qing Wei
Journal:  BMC Syst Biol       Date:  2018-04-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.